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Abstract
Cytomegalovirus (CMV) is frequently transmitted by solid organ transplantation and is associated with graft failure. By
forming the boundary between circulation and organ parenchyma, endothelial cells (EC) are suited for bidirectional virus
spread from and to the transplant. We applied Cre/loxP-mediated green-fluorescence-tagging of EC-derived murine CMV
(MCMV) to quantify the role of infected EC in transplantation-associated CMV dissemination in the mouse model. Both EC-
and non-EC-derived virus originating from infected Tie2-cre
+ heart and kidney transplants were readily transmitted to
MCMV-naı ¨ve recipients by primary viremia. In contrast, when a Tie2-cre
+ transplant was infected by primary viremia in an
infected recipient, the recombined EC-derived virus poorly spread to recipient tissues. Similarly, in reverse direction, EC-
derived virus from infected Tie2-cre
+ recipient tissues poorly spread to the transplant. These data contradict any privileged
role of EC in CMV dissemination and challenge an indiscriminate applicability of the primary and secondary viremia concept
of virus dissemination.
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Introduction
Human Cytomegalovirus (HCMV), a member of the betaher-
pesvirus subfamily, represents an important opportunistic viral
pathogen in the immune compromised host. Fetuses, AIDS
patients, and recipients of both bone marrow and solid organ
transplants are at high risk for the development of debilitating and
potentially life-threatening CMV disease. Depending on the risk
constellation and immunosuppressive regimen, CMV disease can
occur in up to 60% of heart or kidney transplant recipients.
Therefore, HCMV is the most important viral pathogen especially
during the first six months after transplantation [1,2]. The large
variety of symptoms results from the broad cell and organ tropism
of the virus [3,4]. In addition, the virus is able to disseminate via
blood [5]. According to Fenner (1949) a virus enters - after initial
replication at the entry site (epithelia or transplant) - the blood
stream and disseminates throughout the body to distal organs via a
so-called primary viremia, which was confirmed to apply also to
HCMV and MCMV [6,7]. It is proposed that progeny virus from
such organs can re-enter the blood circulation leading to a
secondary viremia [6,7] thus increasing the risk for widespread
dissemination.
Leukocyte depletion of blood products derived from seropositive
donors prior to transfusion efficiently prevents transfer of CMV to
seronegative recipients [8,9] indicating that virus present in blood
is predominantly cell associated. The cell types responsible for this
dissemination are of particular interest. Three kinds of cells have
been suggested to be involved in virus dissemination via blood. All
of them have been shown to be able to transfer infectious virus ex
vivo: polymorphonuclear leukocytes (PMNL), monocytes/macro-
phages, and detached infected vascular endothelial cells (EC).
Although PMNL are thought to be only abortively infected, they
might still function as vehicles for infectious virus [10]. Circulating
infected monocytes become permissive upon differentiation into
tissue macrophages and may then release infectious progeny
within target organs [11]. For example, rat CMV was transferred
via in vitro infected granulocytes or monocytes [12]. Vascular EC
are suggested to play an important role in CMV dissemination,
and unique genetic features govern the CMV - EC interaction
[13]. EC support productive infection and may detach upon
infection thus serving as shuttles for the virus to other organs via
the blood stream [14,15,16]. EC are permissive for HCMV in vitro
[3] and are commonly found to be infected in tissue samples from
both immune compromised patients [17] and mice [18]. In
addition, EC support latent infection with the potential to
reactivate CMV [19] and to start a new episode of infection.
Notably, HCMV infection is a risk factor for restenosis after
coronary atherectomy [20] and accelerates atherosclerosis follow-
ing cardiac transplantation [21]. The anatomical position of EC
lining blood vessels implies a bidirectional role in virus entry into
and exit from the blood circulation and therefore might define the
ability of viruses in general to disseminate via blood. In fact,
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the blood vessels in patients with active cytomegalovirus infection
[16]. Furthermore, circulating giant endothelial cells were found in
blood samples of transplant patients [14] suggesting detachment of
infected EC from the vessel wall and dissemination of HCMV via
EC throughout the body.
Despite the undisputed and unique potential of EC in CMV
infection and pathogenesis, it is still unknown whether infected EC
are responsible for systemic virus dissemination during primary
infection, contribute to this process, or merely represent an
epiphenomenon with no causal involvement in the pathogenesis of
organ disease [22]. Quantitative aspects of the contribution of
infected EC to virus dissemination in the transplant situation are
scarce and the presence of infected EC in the circulating blood
does not prove that infected EC or HCMV produced by EC
contribute or even govern virus dissemination from one site or
organ to another.
To quantify and to address the fate of virus produced by specific
cells, we developed a Cre/loxP mediated approach to label virus in
defined cell types in vivo and then trace the viral progeny of that cell
type [23,24]. Cre recombinase recognizes two adjacent loxPsites and
deletes the intervening DNA sequence. This reaction can remove a
transcriptional stop signal between promoter and coding sequence
resulting in gene expression. To study the role of EC in MCMV
replication an MCMV mutant was used that contains a Cre-
inducible egfp expression cassette (MCMV-flox). Mice expressing Cre
recombinase under control of either the Tie2 or the Tek promoter,
which is selectively expressed in vascular EC (Tie2-cre and Tek-cre
mice), were infected with MCMV-flox. In this in vivo infection model
MCMV-flox is efficiently recombined resulting in MCMV-rec only
during virus replication in EC. It is important to note that Cre-
mediated recombination of MCMV-flox is equally efficient in Tie2-
and Tek-cre mice and only mediated by EC - as shown using bone
marrow chimeras - thus providing highly concordant results by both
mouse strains [24]. The resulting recombination is then stably
maintained in the viral genome of the virus progeny.
Vascular EC are present in all organs. A way to study the role of
EC in virus dissemination from one organ to another is to either
introduce organs from an EC cre-negative donor mouse into an EC
cre-positive host or vice versa. Here, we investigated export of EC-
derived virus from heart and kidney transplants to recipients as
well as import of EC-derived virus from recipients into heart
transplants. This was achieved by counting and comparing the
contribution of EGFP-positive EC-derived progeny to the total
virus load of organs and tissues.
EC-derived virus from infected heart or kidney transplants
readily disseminated to organs of MCMV-naı ¨ve recipients. The
bulk of virus produced in and disseminated from heart is EC-
derived, whereas in kidneys infected EC only provide a minor
contribution. Yet, we found no evidence for any preferential
dissemination of EC-derived virus from both types of transplants
to other organs. The heart transplant was also tested as a target
organ of EC-derived virus produced in recipient tissues. To our
surprise, in contrast to the strong dissemination of virus originating
from an infected transplant there was only minimal seeding of host
EC-derived virus progeny to the transplant. Interestingly, this was
independent of whether transplantation was performed prior to or
after systemic host infection. In summary, our data argue against a
privileged role of EC in virus dissemination.
Results
Virus dissemination from infected hearts into non-
infected recipients
Transplantation of organs from HCMV seropositive donors to
seronegative recipients (D+/R-) is a known situation in transplan-
tation medicine and represents the ‘‘high risk constellation’’
because up to 60% of the recipients can develop CMV disease
[25]. In this D+R- setting CMV disease is caused by dissemination
of HCMV from the transplanted organ to the recipient causing
systemic symptoms with multiple organs being involved. The
cellular source of disseminated virus has not been addressed, yet
virus dissemination from infected heart transplants has also been
described in the mouse model [26,27]. To investigate whether and
to which extent virus derived from EC of the transplant
disseminates to organs of uninfected recipients, hearts from
acutely infected Tie2-cre mice were transplanted heterotopically
into non-infected syngeneic C57BL/6 mice (Fig. 1A). Four days
after transplantation mice were sacrificed and organs collected to
determine the amounts of non-recombined (non-EC-derived) and
recombined (EC-derived) virus. In the heart transplant, high virus
loads (,10
5 PFU/g organ) of predominantly recombined virus
(,85%) were observed, confirming that the transplantation
procedure itself did not affect MCMV replication in general and
demonstrating a very high recombination efficiency (Fig. 1B). This
is in accordance with high recombination efficiency observed
previously for heart and lungs of Tie2-cre mice [24]. Virus titers in
different organs of mice infected via the heart transplant were 10
to 10,000-fold lower than generally seen following systemic (i.v.)
infection with ,1610
6 PFU [24]. The relative amounts of
MCMV-rec and MCMV-flox in the recipient organs, however,
essentially reflected the situation in the heart transplant, with some
minor variance. Thus, EC-derived virus virtually disseminated
equally well as non-EC-derived virus from the heart transplant.
Virus dissemination from infected kidneys into non-
infected recipients
Next, we studied dissemination of MCMV following kidney
transplantation. Kidneys represent the majority of transplanted
organs in medicine. Similar to heart transplantation, the
transplantation of kidneys from seropositive donors to seronegative
recipients is associated with a high risk to develop CMV-related
Author Summary
More than sixty years ago Frank Fenner proposed that
virus dissemination during acute infection originates from
organs replicating virus to high titer (often liver or spleen)
early in infection. Although never formally proven, this
model has become commonly accepted and was applied
to acute virus infections in general. Recently, we chal-
lenged this model by showing that - during acute murine
cytomegalovirus infection – hepatocyte-derived virus
hardly disseminates to other organs. We now applied our
well established model of Cre/loxP-mediated green-
fluorescence-tagging of MCMV to determine and quantify
the role of infected endothelial cells (EC) in transplanta-
tion-associated CMV dissemination. We observed an only
very poor dissemination of MCMV from the transplant to
recipient tissues and vice versa. Interestingly, we observed
no evidence for preferential dissemination of EC-derived
virus. Significant differences in virus organ titers were
found when comparing intravenous infection with trans-
plant-mediated infection. This suggests a preferential
dissemination of cell-associated virus in the transplant
setting. In summary, our findings argue for a preferential
dissemination of cell-associated MCMV but demonstrate
that the Fenner model does not apply to MCMV.
Dissemination of Endothelial Cell-Derived CMV
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tation of infected kidneys of Tie2-cre mice into non-infected
C57BL/6 mice, recipient organs were analyzed for the presence of
disseminated virus (Fig. 2A). In contrast to the heart, only about
20% of virus within transplanted kidneys was recombined (Fig. 2B).
This low contribution of EC-derived virus to total virus load in
kidney is in line with previous observations [24]. As recombination
rates were similar in Tie2-cre and Tek-cre mice, we believe that
the low proportion of MCMV-rec in Tie2-cre kidneys does not
necessarily indicate a low recombination efficiency in renal EC but
may rather result from an alternative mode of virus entry into
kidney tissue bypassing the vascular endothelium for replication in
other cell types, one candidate being kidney epithelial cells. The
relative levels of virus titers in liver, spleen, and lungs were
comparable to those observed following heart transplantation. Yet,
the percentage of recombined, EC-derived virus in most organs
essentially mirrored the situation in the transplanted kidney, and
there was no preferential dissemination of EC-derived virus
(,20%). Collectively, the findings after transplantation of two
different organs did not support the hypothesis of a predominant
role of EC in virus dissemination during the first four days of
infection. Only in blood a significantly higher proportion of
MCMV-rec was found on day four post kidney transplantation in
3 out of 4 mice. However, as the absolute virus titers were close to
the detection limit, any interpretation has to be seen with caution.
Minor contribution of EC-derived virus from the
transplanted heart to virus dissemination in the
systemically infected host
In the preceding experiments, the systemic infection originated
from a pre-infected transplanted organ. Next, we studied the
contribution of EC of a transplanted Tie2-cre
+ heart to virus
dissemination during the situation of systemic infection of C57BL/
6 recipients. Under these conditions, all organs, including the
transplanted heart, become infected simultaneously. Thus,
MCMV-rec, wherever found, must have originated from ECs of
the transplant. Note that under such conditions the infection of the
transplant does not have a head start. Four days after
transplantation mice were systemically (i.v.) infected with
Figure 1. Dissemination of EC- and non-EC-derived MCMV from heart transplants to non-infected recipients via primary viremia. A.
Tie2-cre mice (n=5) were infected i.v. with 8610
5 PFU MCMV-flox. Three days after infection, hearts were transplanted into non-infected C57BL/6
mice. Four days after transplantation blood was taken and organs were collected from recipients to determine the contents of MCMV-flox and
MCMV-rec plaque forming units (PFU) in various organs by plaque assay. B. The graph depicts virus load of MCMV-flox (open circles) and MCMV-rec
(grey circles) per gram organ or ml blood for individual mice referring to the logarithmic scale on the right hand side. Open and grey circles are
connected via a vertical line indicating that these data are derived from the same individual mouse. Horizontal bars mark mean values of absolute
amounts of MCMV-rec (grey) and MCMV-flox (open). Dotted horizontal lines give detection limits of absolute amounts of PFU per gram organ or ml
blood. Grey columns refer to the linear scale on the left hand side of the graph and show the mean percentage of EGFP
+ plaques (MCMV-rec
compared to MCMV-rec plus MCMV-flox), with the standard deviation indicated by vertical bars. Columns labeled with asterisks are calculated for
virus-containing organs only. In both blood and kidney (x) virus titers where too low to reliably calculate the contribution of EC-derived virus.
Abbreviations: he=heart; bl=blood; li=liver; sp=spleen; lu=lungs; ki=kidney; at=adipose tissue; sg=salivary glands.
doi:10.1371/journal.ppat.1002366.g001
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titers determined (Fig. 3A). As expected, the majority of virus in
the transgenic heart transplant was found to be recombined
(Fig. 3B). Despite this, we observed only very little dissemination of
EGFP+ EC-derived MCMV from the transplant to infected
recipient organs. In the lungs, some MCMV-rec was found at very
low numbers, four orders of magnitude lower than MCMV-flox,
whereas in other organs MCMV-rec was at or below detection
limit. This result is in stark contrast to the dissemination from the
infected transplant (Fig. 1) where 70-90% of virus progeny in
recipient organs were EC-derived. It is important to note that total
virus titers in both the endogenous and transplanted heart were
very similar (Fig. 3B), indicating efficient vascularization of the
heterotopic heart transplant after surgery. This excludes an
impaired blood flow as a presumed reason for the observed poor
dissemination of recombined virus. We thus conclude that virus
dissemination from the heart plays a negligible role during
systemic infection.
Another striking difference between virus dissemination from
both transplanted heart and kidney as compared to systemic (i.v.)
infection was the extent of virus production in different organs. In
contrast to i.v. infection, which resulted in peak titers in the lung
and high titers in heart, kidney, liver, spleen and adipose tissue
(Fig. 3), virus dissemination from transplanted heart and kidney
(Figs. 1 and 2) resulted in peak titers in spleen but significantly
lower titers in liver and lung, and in almost no virus detectable in
the endogenous heart, kidneys, and adipose tissue. This cannot
simply be explained by organ specific differences in virus
production kinetics [24] but rather indicates a qualitative
difference in virus dissemination between systemic (i.v.) infection
(free virus) and transplant-mediated infection.
Limited colonization of the heart by EC-derived virus via
secondary viremia
During systemic infection following transplantation of a cre-
positive heart to a cre-negative mouse no significant contribution of
virus dissemination from the heart transplant to other organs was
observed. To study not only cardiac EC but EC in general as a
source of virus dissemination, Tie2-cre or Tek-cre recipient mice
received a non-transgenic heart. Recipients were then infected i.v.
Figure 2. Dissemination of EC- and non-EC-derived MCMV from kidney transplants to non-infected recipients via primary viremia.
A. Tie2-cre mice (n=4) were infected i.v. with 8610
5 PFU MCMV-flox. Three days after infection kidneys were transplanted into non-infected C57BL/6
mice. Four days after transplantation blood was taken and organs were collected from recipients and analyzed. B. Data are depicted as described in
Fig. 1A. Virus load of MCMV-flox (open circles) and MCMV-rec (grey circles) per gram organ or ml blood for individual mice are shown. Grey columns
indicate the mean percentage of EGFP
+ plaques (MCMV-rec compared to MCMV-rec plus MCMV-flox). Abbreviations: he=heart; bl=blood; li=liver;
sp=spleen; lu=lungs; ki=kidney; at=adipose tissue; sg=salivary glands.
doi:10.1371/journal.ppat.1002366.g002
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the previously described organ-specific contribution of EC to total
virus load [24]. Specifically, in liver the bulk of virus is derived
from hepatocytes as we recently showed using Alb-cre mice
selectively expressing Cre recombinase in hepatocytes [24],
whereas the cell type producing the bulk of virus in kidney
remains to be determined. In all other organs, .60% of virus
proved to be EC-derived. Yet, although the transplanted heart
contained a total virus load comparable to that of the endogenous
heart, there was only a minute (about 1%) contribution of
recombined virus to the amount of virus in the transplant (Fig. 4B).
We repeated the experiments in Tek-cre mice, another mouse line
transgenic for cre in EC, and obtained essentially the same results
(Fig. 4C). To confirm that this small contribution of MCMV-rec to
the infection of a heart transplant was truly due to virus seeding to
the organ and not just reflected virus present in the circulation,
organ perfusion was performed in order to flush out blood cells
prior to analysis (Fig. 4C). In any case, the data revealed an only
minute dissemination of EC-derived virus via secondary viremia
following systemic infection.
Dissemination of EC-derived MCMV from an infected
host to a transplant
The low degree of dissemination of MCMV-rec into the heart
could be the result of two scenarios. We expected that the
immune response induced by systemic infection actively prevent-
ed secondary import of EC-derived virus into the transplant.
Alternatively, after initial virus seeding by systemic (i.v.) infection,
local virus production might simply outnumber secondary import
of EC-derived virus. To address this issue and to initiate the
activation of immune functions, systemic infection was performed
prior to transplantation. Specifically, Tie2-cre or Tek-cre mice
were first i.v. infected with MCMV-flox and only then received
heart transplants of non-infected C57BL/6 mice either 20 h or 3
days after infection (Fig. 5A/B). Strikingly, systemic infection
prior to transplantation increased the relative contribution of EC-
derived virus in the transplant from ,5% (Fig. 4B) to ,60%
independent of the time delay between infection and transplan-
tation (Fig. 5A/B). This average of about 60% MCMV-rec
reflects the average contribution of MCMV-rec in the organism
in general. However, total virus titers in the heart transplant were
100- to 1000-fold lower than in both the endogenous heart
exposed to i.v. infection as well as the hearts transplanted prior to
i.v. infection (Fig. 4B/C). It is important to note that the absolute
amounts of recombined virus in the heart transplants (grey circles
in Fig. 5A/B) were on the same level with those observed
following i.v. infection after heart transplantation (grey circles in
Fig. 4B/C). Similar results were obtained after perfusion of
recipient organs thus demonstrating that the detected virus was
not blood-borne but was indeed produced within the transplanted
organ.
Figure 3. Little dissemination of EC-derived MCMV from heart transplants via secondary viremia. A. Hearts from Tie2-cre mice were
transplanted into C57BL/6 mice (n=5). Four days later recipients were infected i.v. with 8610
5 PFU MCMV-flox. Blood was taken and organs were
collected four days after infection and analyzed. B. Data are depicted as described in Fig. 1A. Virus load of MCMV-flox (open circles) and MCMV-rec
(grey circles) per gram organ or ml blood for individual mice are shown. Grey columns indicate the mean percentage of EGFP
+ plaques (MCMV-rec
compared to MCMV-rec plus MCMV-flox). Abbreviations: he=heart; bl=blood; li=liver; sp=spleen; lu=lungs; ki=kidney; at=adipose tissue;
sg=salivary glands.
doi:10.1371/journal.ppat.1002366.g003
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PLoS Pathogens | www.plospathogens.org 5 November 2011 | Volume 7 | Issue 11 | e1002366Figure 4. Minor colonization of heart transplants by EC-derived MCMV via secondary viremia following systemic infection. A. Hearts
from C57BL/6 mice were transplanted into Tie2-cre (n=5; B.) or Tek-cre mice (C.) and recipients were infected i.v. with 8610
5 PFU MCMV-flox four to
five days later. Five days after infection blood was taken and organs were collected from recipients and analyzed. Data are depicted as described in
Dissemination of Endothelial Cell-Derived CMV
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was delayed from 20 h to 3 days after infection, reflecting the
situation at day 5 and 7 p.i., respectively. In two animals
transplanted three days after infection, virus titers in the heart
transplant even fell below the detection limit of 10 PFU/g organ,
probably reflecting enhanced control by the host immune system
at day 7. This is supported by the relatively low virus titers in
spleen, kidneys and adipose tissues as well as by the lack of
detectable virus in blood (Fig. 5B).
In conclusion, we were surprised to see that ongoing virus
replication and the accompanying immune response in the
transplanted heart did obviously not alter the absolute amount
of EC-derived virus originating from recipients’ tissues by
secondary viremia. These data demonstrate that virus dissemina-
tion between organs – originating from both endothelial and non-
endothelial cells – has only minor effects on organ viral load
following systemic infection.
Discussion
One hallmark of CMV infection is the ability of the virus to
infect many cell types and tissues from which again the virus may
spread. Apparently, immune control defines to which extent this
potential is realized in a given scenario. Therefore, the various
clinical conditions need to be considered to explain CMV
pathogenesis. Blood specimens play an important role in CMV
diagnostics. Proper usage of the information gained by this analysis
should monitor or even predict events that happen in organs.
However, it is currently unclear under which conditions CMV is
spread via blood. Fenner et al. were the first to propose a two-step
dissemination model for systemic virus infections. Primary viremia
transports the virus from the site of entry to liver and spleen where
the virus replicates. Secondary viremia then causes dissemination
from liver and spleen throughout the body [31]. This model
became widely accepted for many viruses to this day, including
CMV [6,32]. Yet, the original model was developed prior to any
knowledge on innate immunity control functions and did thus not
consider major factors in virus host defense. Recently, we
challenged this view for CMV infection in the mouse model with
respect of the role of the liver. Virus produced in hepatocytes is
locally disseminated to other cell types but is not distributed from
the liver to other organs via secondary viremia [24].
In the present study the vascular EC were analyzed for their
claimed role in contributing to the CMV load in organs, and in
disseminating the virus via primary or secondary viremia. Our
salient findings are as follows: EC-derived virus significantly,
,50% of the body virus pool, contributes to total virus load during
acute infection. This contribution was quantified for the first time
for the major organs. Yet, there was obviously no preference for
dissemination of EC-derived virus over virus produced by other
cell types. In addition, and similar to hepatocyte-derived virus,
EC-derived virus was poorly disseminated via secondary viremia.
These data raise doubts on the indiscriminate applicability of the
primary and secondary viremia concept to virus infections in
general.
Properties of EC have enticed scientists to consider them as key
production sites for virus dissemination, as they may release free
virus particles directly into the blood stream or may detach from
the vessel wall and transfer virus to other organs via the blood
stream [14,15]. Moreover, EC could transfer the virus by contact
to other cell types such as monocytes or granulocytes [33,34],
which would then disseminate the EC-derived virus to other
organs [12,35]. On the other hand, EC-derived virus may also
spread to underlying parenchyma and leave the organs via the
draining lymph nodes to eventually reach the blood circulation via
the thoracic duct. As heterotopic, abdominal transplants are not
connected to lymph vessels, exiting virus would enter the
peritoneal cavity that is drained by the mediastinal lymph nodes.
This lymphatic dissemination route was recently described after
intraperitoneal MCMV infection [36] and is also generally
accepted as dissemination route after local infections, including
intraplantar infection with MCMV [37].
Here, we provide the first quantitative analysis of organ- and
cell type-specific virus dissemination. From an infected organ EC-
derived virus readily disseminated to the other, uninfected organs.
In the specific cases shown here, the infected transplanted organ
(heart or kidney) created the condition of a primary viremia
initiating from a defined source. EC-derived virus remained a
stable fraction in both heart (,80%) and kidney (,20%)
throughout the first week of infection [24], thereby providing a
constant supply of virus. Yet, the percentage of EC-derived virus
that disseminated to other organs essentially mirrored the relative
contribution of EC in the transplanted organ. Thus there was no
preferential seeding of EC-derived virus.
Infected EC might detach from the vessel wall and circulate. In
fact, HCMV-infected EC were considered as a parameter for the
diagnosis of HCMV organ involvement and for the study of the
pathogenesis of disseminated infection [16]. This conclusion was
originally based on the finding of two symptomatic patients with a
high load of infected circulating EC, but experimental evidence for
EC-derived virus colonizing other organs was missing so far. In the
mouse model we now provide a nuanced view on the role of EC in
virus dissemination. If the infected heart transplant is the source of
primary infection, then EC-derived virus is readily disseminated,
but without preference. During secondary viremia, however, there
is only negligible import of EC-derived virus into the transplant as
well as export from the transplant, and this is apparently
independent of the extent of ongoing virus replication, associated
inflammation, and immune control.
Do our findings formally exclude any prominent role of EC-
derived virus? The answer is both yes and no. Yes, we can exclude
this role in the mouse model and for the temporal conditions of
our experiments. Unfortunately, the more time passes after initial
infection of the animal the definition of virus as being EC-derived
virus becomes more and more indirect. EC-derived virus progeny
keeps the marker independent of the cell type in which the virus
replicates in further replication rounds. Thus, with our experi-
mental setup we cannot study later phases of infection when other
conditions of virus productivity and dissemination may prevail.
However, according to our previous experience, second and third
replication rounds contribute less and less to the viral load in the
immune competent host due to the onset of immune control [24].
We have not yet studied the situation of the immune deficient host
for the EC progeny. For the hepatocyte-derived progeny, however,
we know that immune suppressive regimens, even if combined, do
not lift the strong dissemination block [24].
Nevertheless, by comparing the virus titers in different organs
following transplant-derived and i.v. infection, we observed
Fig. 1A. In (C.) organs were removed from non-perfused (left hand panel, n=5) or perfused (right hand panel, n=3) recipient mice. Data of non-
perfused and perfused groups were obtained in different experiments. Abbreviations: he=heart; bl=blood; li=liver; sp=spleen; lu=lungs;
ki=kidney; at=adipose tissue; sg=salivary glands.
doi:10.1371/journal.ppat.1002366.g004
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PLoS Pathogens | www.plospathogens.org 7 November 2011 | Volume 7 | Issue 11 | e1002366Figure 5. Minor colonization of heart transplants via secondary viremia. Tek-cre mice (n=3; A) or Tie2-cre (n=4; B) were infected i.v. with
8610
5 PFU MCMV-flox and received a heart transplant derived from non-infected C57BL/6 mice 20 hours (A) or three days (B) later. Four days after
transplantation blood was taken and organs were collected from recipients and analyzed. Data are depicted as described in Fig. 1A. In (A), recipient
Dissemination of Endothelial Cell-Derived CMV
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produced virus preparations resulted in a uniform distribution of
virus to many organs, whereas transplant-derived virus appeared
to preferentially colonize spleen, lung and liver but not heart,
adipose tissues and kidneys. This cannot be explained by known
differences in organ specific virus kinetics. Therefore, cell-free
virus, which is usually used for experimental infection, is
apparently able to efficiently colonize all organs, whereas virus
leaving an infected organ via a natural route reveals a different
kind of spread. What could be the cause of the difference between
i.v. infection with a solution enriched in isolated virions and the
spread of infection from an infected organ? The most plausible
explanation is that the virus leaving an infected organ during
systemic infection is predominantly transported in a cell-associated
manner. Yet, this difference in organ and tissue distribution shows
no preference for EC-derived virus and is altogether marginal with
respect to total virus load in an organ.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations and guidelines for the care and use of laboratory
animals according to Tierschutzgesetz (TierSchG, BGBI S. 1105;
25.05.1998). All animal experiments were approved by the
responsible state office (Regierung von Oberbayern) under permit
number 55.2-1-54-2531-19-07.
Cells and mice
M2-10B4 (CRL-1972; ATCC) and BALB/c-derived mouse
embryo fibroblasts (MEF) were grown as described previously
[38]. Transgenic Tie2-cre [39] and Tek-cre [11] mice were housed
at the animal facility of the Max von Pettenkofer-Institute under
specified-pathogen-free (SPF) conditions. Cre-transgenic mouse
strains were maintained on the C57BL/6J background. Experi-
ments were performed with gender matched pairs of mice at 3 to
12 months of age. C57BL/6J mice were obtained from Janvier.
Tek-cre mice were obtained from Jackson Laboratories (nr. 4128).
Viruses and infection of mice
All viruses were derived from the molecular clone pSM3-fr [40].
Mutant virus (MCMV-flox) was generated as described [24].
Viruses were propagated on M2-10B4 cells and purified as
described [41]. Virus quantification was done by standard plaque
titration assay on MEF. Mice were infected intravenously (i.v.; into
a tail vein) with 8610
5 PFU in a volume of 300 ml.
Organ transplantations
Syngeneic transplantations of hearts or kidneys were performed
between C57BL/6 mice and Tie2-cre or Tek-cre mice that were
maintained on the genetic background of C57BL/6 mice.
Heart transplant model: Abdominal-heterotopic cardiac trans-
plants were performed, as previously described [42]. Briefly, the
ascending aorta of the graft was anastomosed to the abdominal
aorta of the recipient and the pulmonary artery to the inferior
vena cava while the pulmonary veins were ligated. The graft
function was assessed by daily palpation.
Kidney transplant model: The murine kidney transplantation
was performed as described previously [43]. Briefly, the left kidney
of the donor was harvested and transplanted into the recipient.
The kidneys of the recipients were not removed. A bladder patch
was anastomosed to the recipient’s bladder. No signs of rejection
due to Cre expression by EC of the transplants or by EC of the
recipient were seen throughout the experiments excluding host
versus graft or graft versus host reactions, respectively.
Virus determination in organs
Virus load in organs was determined by plaque assay as
described previously [24] with the modification that blood samples
were sonicated before they were added to MEF in a volume of
10 ml per well. The numbers of MCMV-rec and MCMV-flox
plaque forming units (PFU) were determined from organ
homogenates after 4 days and from blood after 5 days using a
fluorescence microscope (Olympus). Only plaques visible in bright
field were considered for the calculation. PFU were calculated per
ml of blood or g of organ.
Perfusion of recipients and heart transplants
Mice were anaesthetized and the peritoneal cavity was opened.
After injection of 50 ml of heparin into the inferior vena cava,
abdominal aorta and vena cava were cut cranially of the
transplant. After all organs were perfused with 5 ml PBS via the
vena cava the heart transplant was removed and perfused
separately with 3 ml PBS.
Statistical analysis
The percentage of MCMV-rec compared to total virus organ
load per group, mean values, and standard deviations were
determined.
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